Stocksigma LogoStocksigma Logo

Vaishali Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

■ Revenue: 3,017 (-9.8% YoY | +31.8% QoQ) ■ EBITDA: 205 (+47.7% YoY | +38.2% QoQ) ■ EBITDA Margin (%): 6.8 (+265 bps YoY | +32 bps QoQ) ■ PAT: 206 (+73.6%

Vaishali Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

Vaishali Pharma Ltd · Outcome · 15 Nov 2026, 1:11 am

Vaishali Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 3,017 (-9.8% YoY | +31.8% QoQ) ■ EBITDA: 205 (+47.7% YoY | +38.2% QoQ) ■ EBITDA Margin (%): 6.8 (+265 bps YoY | +32 bps QoQ) ■ PAT: 206 (+73.6% YoY | +33.2% QoQ) ■ EPS (INR): 0.16 (+77.8% YoY | +33.3% QoQ)

Original exchange filing (PDF)

More announcements from Vaishali Pharma Ltd

All Vaishali Pharma Ltd announcements